Header Logo

Connection

Frederick Raal to Angiopoietin-like Proteins

This is a "connection" page, showing publications Frederick Raal has written about Angiopoietin-like Proteins.
Connection Strength

1,908
  1. Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia. Curr Opin Lipidol. 2021 08 01; 32(4):213-218.
    View in: PubMed
    Score: 0,758
  2. Evinacumab for Homozygous Familial Hypercholesterolemia. N Engl J Med. 2020 08 20; 383(8):711-720.
    View in: PubMed
    Score: 0,710
  3. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis. Curr Atheroscler Rep. 2022 12; 24(12):959-967.
    View in: PubMed
    Score: 0,207
  4. Novel therapies for familial hypercholesterolemia. Curr Opin Endocrinol Diabetes Obes. 2021 04 01; 28(2):188-195.
    View in: PubMed
    Score: 0,185
  5. Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3. Future Cardiol. 2022 02; 18(2):143-153.
    View in: PubMed
    Score: 0,048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.